Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion type Assertion NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_head.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion description "[the prevalence of APC resistance (and FVL) is increased in patients with RVO compared to controls, but the effect is only moderate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_provenance.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion evidence source_evidence_literature NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_provenance.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion SIO_000772 18449423 NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_provenance.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion wasDerivedFrom gad-20150221 NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_provenance.
- NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_assertion wasGeneratedBy ECO_0000203 NP122521.RAfDT70nULEJ4urY7qZM8Rj32TXWzQdcz6lKYzoqdN5bU130_provenance.